Booth 1A18 will feature key excipient brands, an upcoming capsule range extension, and an engaging interactive zone

Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and leading technical expertise at CPHI Milan 2026 in Italy, where the company will welcome visitors at booth 1A18 in the excipients hall.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260929017969/en/

Visit Roquette at booth 1A18 in the excipients hall.

At this year’s global industry event, Roquette will highlight key product brands supporting formulation performance, patient-centric drug delivery and biopharma innovation, including METHOCEL™ cellulose ethers, PEARLITOL^® mannitol, Avicel^® microcrystalline cellulose, POLYOX™ polyethylene oxide, KLEPTOSE^® cyclodextrins, LYCADEX^® pyrogen-free dextrose monohydrate, Qualicaps™ by Roquette hard capsules and its alginate portfolio from sustainably sourced seaweed. The company will also spotlight its biopharma solutions spanning upstream processing, downstream efficiency, and formulation support.

Visitors to the booth will be able to preview the newest addition to the Qualicaps™ portfolio designed to expand the hard capsule choices available to pharmaceutical manufacturers while maintaining the quality and reliability you expect from Qualicaps™ by Roquette.

Roquette will also feature an engaging interactive zone where visitors can experience a world of robust excipient solutions through entertaining digital experiences, with a chance to win prizes.

“Pharmaceutical innovation is ultimately measured by the difference it makes in patients’ lives,” said Chiara Bergerone, Deputy CEO of Roquette’s Health & Pharma Solutions Business Unit. “At CPHI Milan, we will show how the right combination of science, technology and partnership can turn complex formulation challenges into solutions that are more effective, reliable and meaningful for patients.”

At booth 1A18, Roquette’s experts will be available to discuss solutions for oral solid dosage, parenteral, drug delivery and biopharma applications.

About Roquette

Roquette is a global leader in sustainable plant-based solutions, driving innovation and strong partnerships that are shaping the future of nutrition, health, and bioindustry.

The company harnesses natural resources such as wheat, corn, seaweed, and cellulose to craft high-performance ingredients used in everyday foods, oral medications, advanced biopharmaceuticals, and a range of bio-based products.

A family-owned company with over 90 years of expertise and 11,000 employees, Roquette serves clients in over 150 countries and is committed to creating lasting value for customers, patients, consumers, and society.

Together, we turn the potential of nature into the essentials of life.

Discover more about Roquette here.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260929017969/en/

Press Contact:
Lisa M. Miree Luke
Global Head of Communications
Roquette’s Health & Pharma Solutions Business Unit
Email: lisa.luke@roquette.com

Logo

Images

Tags

More Like This

Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 2026

Roquette Showcases Its Expanded Consumer Healthcare Capabilities at Vitafoods Europe 2026

New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub

IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025

IFF Announces Sale of its Pharma Solutions Business to Roquette

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025

SK pharmteco to Attend CPHI, Showcasing Multimodal CDMO Capabilities and Global Manufacturing Infrastructure

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023